Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRSA throat carriage decolonization with or without oral clindamycin
2019-002631-29Phase 3Active
- Sponsor
- MRSA Knowledge Center
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in methicillin-resistant Staphylococcus aureus nasal colonization (MRSA) comparing Standard decolonization therapy + placebo with Standard decolonization therapy + clindamycin (2 arms). Primary endpoint: MRSA-negative throat swab at 1 month. Started Aug 2019; status: active.
02
Drugs
clindamycin
03
Conditions
methicillin-resistant Staphylococcus aureus nasal colonization (MRSA)
Beyond the preview
Go deeper on 2019-002631-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002631-29.